TABLE 1.
Ad isolates by site and species from non-HIV-infected and HIV-infected individuals from The Netherlands and the United Kingdom
HIV infection | Specimen source | No. (%) of the following speciesa:
|
|||||||
---|---|---|---|---|---|---|---|---|---|
A | B1 | B2 | C | D | E | F | Total | ||
No | All sitesb | 83 (4) | 593 (26) | 14 (1) | 1,119 (49) | 110 (5) | 54 (2) | 328 (14) | 2301 (100) |
Yes | All sitesc | 4 (2) | 2 (1) | 14 (8%) | 6 (3) | 153 (84) | 3 (2) | 182 (100) | |
Yes | Entericc | 3 | 2 | 1 | 3 | 145 | 1 | 155 (85) | |
Yes | Urinec | 1 | 14 | 1 | 2 | 18 (10) | |||
Yes | Respiratoryc | 1 | 1 | 8 | 2 | 12 (7) | |||
Yes | Otherc | 1 | 2 | 3 (2) |
Blank entries, no Ad isolates.
Ads isolated at RIVM from Dutch patients during the period from 1973 to 1992.
Ads isolated in The Netherlands from AIDS patients during the period from 1982 to 1994 and Ads isolated in Manchester from AIDS patients for a previous study (14).